Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.

Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials

Open access
Gamrath, Lone, Pedersen, Tobias Bruun, Møller, Martin Vad, Volmer, Lone Marie, Holst-Christensen, Linda, Vestermark, Lene Weber, Donskov, Frede · 2025 · Current Oncology Reports

Abstract

PURPOSE OF REVIEW: The advent of checkpoint immunotherapy has dramatically changed the outcomes for patients with cancer. However, a considerable number of patients have little or no response to therapy. We review recent findings on the connection between the gut microbiota and the immune system, exploring whether this link could enhance the effectiveness of immunotherapy. RECENT FINDINGS: Clinical studies have reported specific types of bacteria in larger quantities at baseline in responders than in non-responders, especially Akkermansia mucinifila, Ruminococcaceae, Faecalibacterium, and Lachnospiraceae. Following the consumption of a high-fiber diet, bacteria in the gut ferment dietary fiber to short-chain fatty acids (SCFAs), like acetate, propionate, and butyrate. Some of the SCFAs nurture intestinal epithelial cells, and some enter the bloodstream. Here SCFAs can activate DC8 + cytotoxic T-cells to induce cancer cell death. High fiber intake in the diet was associated with a reduced risk of progression or death during checkpoint immunotherapy. Recent findings demonstrate that high-fiber plant-based diets such as the Mediterranean Diet positively influence the gut microbiota whereas antibiotics and proton pump inhibitors can negatively influence outcomes of cancer immunotherapy by changing the gut microbiota. This narrative review provides evidence of an association between types of bacteria and their metabolites and favorable responses to checkpoint immunotherapy. Prospective clinical trials are needed to determine if diet interventions can improve treatment outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11912-024-01622-6

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Following the consumption of a high-fiber diet, bacteria in the gut ferment dietary fiber to short-chain fatty acids (SCFAs). Some of the SCFAs nurture intestinal epithelial cells, and some enter the bloodstream. Here SCFAs can activate DC8 + cytotoxic T-cells to induce cancer cell death by binding to mammalian G protein-coupled receptors (GPCR) 41 and 43. This unique ligand specificity suggests that GPCR41 and GPCR43 may mediate the interaction between the gut microbiome and the human host
Fig. 1 Following the consumption of a high-fiber diet, bacteria in the gut ferment dietary fiber to short-chain fatty acids (SCFAs). Some of the SCFAs nurture intestinal epithelial cells, and some enter the bloodstream. Here SCFAs can activate DC8 + cytotoxic T-cells to induce cancer cell death by binding to mammalian G protein-coupled receptors (GPCR) 41 and 43. This unique ligand specificity suggests that GPCR41 and GPCR43 may mediate the interaction between the gut microbiome and the human hostCC BY-NC-ND · PubMed Central
Fig. 2 Right panel Summary of factors with strong evidence for positively or negatively affecting immunotherapy treatment outcomes through the microbiome. Left panel Factors that help or hinder dietary changes during cancer treatment
Fig. 2 Right panel Summary of factors with strong evidence for positively or negatively affecting immunotherapy treatment outcomes through the microbiome. Left panel Factors that help or hinder dietary changes during cancer treatmentCC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 69 references

Cited by

See all 30

Metadata

Authors
Gamrath, L., Pedersen, T. B., Møller, M. V., Volmer, L. M., Holst-Christensen, L., Vestermark, L. W., & Donskov, F.
Affiliations
  • Hospital South West Jutland (DK)
  • Vejle Sygehus (DK)
  • University of Southern Denmark (DK)
Corresponding author
Donskov, Frede
Venue
Current Oncology Reports
Published
2025-01
Volume
27
Issue
1
Pages
45-58
ISSN
  • 1523-3790 (ISSN-L)
  • 1534-6269
OpenAlex
W4406026483
Cited by
30
References
69
Citations by year
2026: 17 · 2025: 13
FWCI
2.66
Type
journal article
Language
en
Open access
Licence
Locations
  • Current Oncology Reports (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion, cc-by-nc-nd)
Funders
  • Southwest-Southern Denmark Cancer Fund
  • Danish Cancer Society, Esbjerg
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
gut microbiota, cancer immunotherapy, immune checkpoint inhibitors, treatment response, Ruminococcaceae, Faecalibacterium, Lachnospiraceae, short-chain fatty acids, dietary fiber, high-fiber diet, plant-based diet, Mediterranean diet, antibiotics, proton pump inhibitors, dendritic cells, intestinal epithelium
MeSH terms
Gastrointestinal Microbiome, Immune Checkpoint Inhibitors, Bacteria, Clinical Trials as Topic, Diet, Dietary Fiber, Humans, Immunotherapy, Neoplasms, Metabolome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials. https://app.cochat.ai/papers/10.1007/s11912-024-01622-6
The paper
Gamrath, L., Pedersen, T. B., Møller, M. V., Volmer, L. M., Holst-Christensen, L., Vestermark, L. W., & Donskov, F. (2025). Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials. Current Oncology Reports. https://doi.org/10.1007/s11912-024-01622-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.